Skip to main content
. Author manuscript; available in PMC: 2009 Oct 24.
Published in final edited form as: Circ Res. 2008 Sep 18;103(9):983–991. doi: 10.1161/CIRCRESAHA.108.178970

Figure 8.

Figure 8

Panel A shows the effect of GSK inhibition on Bcl-2 levels in cytosolic and mitochondrial fractions. Panel B shows the effect of GSK inhibition on the amount of Bcl-2 that is immunoprecipitated by VDAC antibodies. *p<0.05 vs control.